Highly productive and scalable approach to synthesize ticlopidine: A potent thienopyridine anti-platelet aggregation drug
Ticlopidine (trade name Ticlid), an acidic thienopyridine derivative, is an effective, well-known and long-acting inhibitor of platelet aggregation. Because of its potent inhibitory activity for treating a variety of diseases, the development of efficient approaches for accessing ticlopidine represe...
Main Authors: | Muhammad Faisal, Quret ul Aein, Aamer Saeed, Amara Mumtaz, Fayaz Ali Larik |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-12-01
|
Series: | Heliyon |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2405844020325743 |
Similar Items
-
Ticlopidine-induced subacute cutaneous lupus erythematosus: A case report and literature review
by: Yi-Ching Chen, et al.
Published: (2014-09-01) -
THE EFFECTIVENESS OF CLOPIDOGREL AS AN ANTITHROMBOTIC COMPARED TO TICLOPIDINE AND ASPIRIN (META-ANALYSIS)
by: Titien Siwi Hartayu, et al.
Published: (2017-05-01) -
Neuroborreliosis in patient with aplastic anaemia secondary to therapy with ticlopidine
by: Čolović Milica, et al.
Published: (2010-01-01) -
Ticlopidine-induced cholestatic hepatitis: A case report and review of the literature
by: Luigi Anastasio, et al.
Published: (2012-10-01) -
Comparison of Clopidogrel and Ticlopidine/Ginkgo Biloba in Patients With Clopidogrel Resistance and Carotid Stenting
by: Jong-Won Chung, et al.
Published: (2019-01-01)